Clinical Trial Update: Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery

View source ↗

Summary

A completed non-interventional study evaluating NovoSeven use in surgery for patients with haemophilia A or B who have inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia with Inhibitors

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A With Inhibitors | Status: COMPLETED